161 related articles for article (PubMed ID: 22854267)
1. Cost-effectiveness in the contemporary management of critical limb ischemia with tissue loss.
Barshes NR; Chambers JD; Cohen J; Belkin M;
J Vasc Surg; 2012 Oct; 56(4):1015-24.e1. PubMed ID: 22854267
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of revascularization for limb preservation in patients with marginal functional status.
Barshes NR; Kougias P; Ozaki CK; Pisimisis G; Bechara CF; Henson HK; Belkin M
Ann Vasc Surg; 2014 Jan; 28(1):10-7. PubMed ID: 24332257
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of the treatments for critical limb ischemia in the elderly population.
Peters CML; de Vries J; Redeker S; Timman R; Eijck GV; Steunenberg SL; Verbogt N; Ho GH; van Busschbach JJ; van der Laan L
J Vasc Surg; 2019 Aug; 70(2):530-538.e1. PubMed ID: 30922757
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of revascularization for limb preservation in patients with end-stage renal disease.
Barshes NR; Kougias P; Ozaki CK; Goodney PP; Belkin M
J Vasc Surg; 2014 Aug; 60(2):369-374.e1. PubMed ID: 24657067
[TBL] [Abstract][Full Text] [Related]
5. The BEST-CLI trial: a multidisciplinary effort to assess whether surgical or endovascular therapy is better for patients with critical limb ischemia.
Menard MT; Farber A
Semin Vasc Surg; 2014 Mar; 27(1):82-4. PubMed ID: 25812762
[TBL] [Abstract][Full Text] [Related]
6. Costs of Real-Life Endovascular Treatment of Critical Limb Ischemia: Report from Poland-A European Union Country with a Low-Budget Health Care System.
Krzanowski M; Drelicharz L; Belowski A; Partyka L; Sumek-Brandys B; Ramakrishnan PK; Nizankowski R
Ann Vasc Surg; 2016 Feb; 31():111-23. PubMed ID: 26616505
[TBL] [Abstract][Full Text] [Related]
7. A comparison of open and endovascular revascularization for chronic mesenteric ischemia in a clinical decision model.
Hogendoorn W; Hunink MG; Schlösser FJ; Moll FL; Muhs BE; Sumpio BE
J Vasc Surg; 2014 Sep; 60(3):715-25.e2. PubMed ID: 24721175
[TBL] [Abstract][Full Text] [Related]
8. Analysis of wound healing time and wound-free period as outcomes after surgical and endovascular revascularization for critical lower limb ischemia.
Okazaki J; Matsuda D; Tanaka K; Ishida M; Kuma S; Morisaki K; Furuyama T; Maehara Y
J Vasc Surg; 2018 Mar; 67(3):817-825. PubMed ID: 29032905
[TBL] [Abstract][Full Text] [Related]
9. Contemporary management of critical lower limb ischemia in TASC D lesions with subintimal angioplasty in femoro-popliteal lesions, tibial angioplasty and sequential compression biomechanical device for infra-inguinal arterial occlusion. Experience and quality of life outcome learned over 25 years.
Sultan S; Hynes N
J Cardiovasc Surg (Torino); 2014 Dec; 55(6):813-25. PubMed ID: 25216216
[TBL] [Abstract][Full Text] [Related]
10. Cost-Effectiveness Analysis of Initial Treatment Strategies for Nonembolic Acute Limb Ischemia Using Real-Word Data.
Vaidya V; Gangan N; Comerota A; Lurie F
Ann Vasc Surg; 2017 Feb; 39():276-283. PubMed ID: 27575302
[TBL] [Abstract][Full Text] [Related]
11. A cost-effectiveness analysis of infrainguinal bypass in the absence of great saphenous vein conduit.
Barshes NR; Ozaki CK; Kougias P; Belkin M
J Vasc Surg; 2013 Jun; 57(6):1466-70. PubMed ID: 23395205
[TBL] [Abstract][Full Text] [Related]
12. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Health-related quality of life outcomes, resource utilization, and cost-effectiveness analysis.
Forbes JF; Adam DJ; Bell J; Fowkes FG; Gillespie I; Raab GM; Ruckley CV; Bradbury AW;
J Vasc Surg; 2010 May; 51(5 Suppl):43S-51S. PubMed ID: 20435261
[TBL] [Abstract][Full Text] [Related]
13. Predictive ability of the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification system following infrapopliteal endovascular interventions for critical limb ischemia.
Darling JD; McCallum JC; Soden PA; Meng Y; Wyers MC; Hamdan AD; Verhagen HJ; Schermerhorn ML
J Vasc Surg; 2016 Sep; 64(3):616-22. PubMed ID: 27380993
[TBL] [Abstract][Full Text] [Related]
14. Multidisciplinary care improves amputation-free survival in patients with chronic critical limb ischemia.
Chung J; Modrall JG; Ahn C; Lavery LA; Valentine RJ
J Vasc Surg; 2015 Jan; 61(1):162-9. PubMed ID: 25073577
[TBL] [Abstract][Full Text] [Related]
15. Lower Extremity Revascularization in End-Stage Renal Disease.
Jones DW; Dansey K; Hamdan AD
Vasc Endovascular Surg; 2016 Nov; 50(8):582-585. PubMed ID: 27770080
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes of bypass-first versus endovascular-first strategy in patients with chronic limb-threatening ischemia due to infrageniculate arterial disease.
Dayama A; Tsilimparis N; Kolakowski S; Matolo NM; Humphries MD
J Vasc Surg; 2019 Jan; 69(1):156-163.e1. PubMed ID: 30579443
[TBL] [Abstract][Full Text] [Related]
17. Sequential compression biomechanical device in patients with critical limb ischemia and nonreconstructible peripheral vascular disease.
Sultan S; Hamada N; Soylu E; Fahy A; Hynes N; Tawfick W
J Vasc Surg; 2011 Aug; 54(2):440-6; discussion 446-7. PubMed ID: 21571490
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes and cost-effectiveness of initial treatment strategies for nonembolic acute limb ischemia in real-life clinical settings.
Lurie F; Vaidya V; Comerota AJ
J Vasc Surg; 2015 Jan; 61(1):138-46. PubMed ID: 25154566
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of endovascular repair, open repair, and conservative management of splenic artery aneurysms.
Hogendoorn W; Lavida A; Hunink MG; Moll FL; Geroulakos G; Muhs BE; Sumpio BE
J Vasc Surg; 2015 Jun; 61(6):1432-40. PubMed ID: 25827968
[TBL] [Abstract][Full Text] [Related]
20. Nationally Representative Readmission Factors in Patients with Claudication and Critical Limb Ischemia.
Martinez RA; Shnayder M; Parreco J; Gaffney L; Eby M; Cortolillo N; Lopez M; Zeltzer J
Ann Vasc Surg; 2018 Oct; 52():96-107. PubMed ID: 29777842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
